{"id":12164,"date":"2008-04-03T10:30:00","date_gmt":"2008-04-03T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/rassegna-stampa-farmaceutica-dall1-al-3-aprile-di-aboutpharma\/"},"modified":"2008-04-03T10:30:00","modified_gmt":"2008-04-03T08:30:00","slug":"rassegna-stampa-farmaceutica-dall1-al-3-aprile-di-aboutpharma","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/rassegna-stampa-farmaceutica-dall1-al-3-aprile-di-aboutpharma\/","title":{"rendered":"PHARMACEUTICAL PRESS REVIEW from 1 to 3 April of AboutPharma"},"content":{"rendered":"

Schering: $1.5 billion in cuts by 2012<\/p>\n

<\/span><\/font><\/strong><\/p>\n

(The Wall Street Journal online - April 3, 2008)<\/p>\n

<\/span><\/font><\/p>\n

Schering-Plough to cut $1.5 billion worth of business costs by 2012 y<\/metricconverter> following the indications of a panel of cardiologists who suggest that doctors limit the prescription of the anti-cholesterol drugs Vytorin (simvastatin + ezetimibe) and Zetia (ezetimibe), marketed together with Merck & Co. Among the items affected by the cuts also that of personnel, who will be reduced by 10% (about 5,500 seats). The company said it will reduce both middle and senior management levels and the number of manufacturing facilities.<\/p>\n

<\/span><\/font><\/p>\n

http:\/\/www.aboutpharma.it\/notizia.asp?id=16298<\/a><\/p>\n

<\/span><\/font><\/p>\n

<\/p>\n

 <\/p>\n

<\/span><\/font><\/p>\n

GSK's anti-AIDS drug increases the risk of heart problems<\/p>\n

<\/span><\/font><\/strong><\/p>\n

(The Wall Street Journal online - April 3, 2008)<\/p>\n

<\/span><\/font><\/p>\n

GlaxoSmithKline's anti-AIDS drug Ziagen (abacavir) doubles the risk of heart attacks, a study published in the Lancet found. EMEA said it will seek more information on the medicine, as no conclusions can be drawn about the medicine's safety from the published study.<\/p>\n

<\/span><\/font><\/p>\n

http:\/\/www.aboutpharma.it\/notizia.asp?id=16296<\/a><\/p>\n

<\/span><\/font><\/p>\n

<\/p>\n

 <\/p>\n

<\/span><\/font><\/strong><\/p>\n

"Cell Therapeutics soars thanks to the opening of EMEA on Xyotax"<\/p>\n

<\/span><\/font><\/strong><\/p>\n

(Free Market: page 3, Bloomberg Finance & Markets: page 4, Corriere della Sera: page 37 \u2013 3 April 2008)<\/p>\n

<\/span><\/font><\/p>\n

Cell Therapeutics' thiol gained 28,53% following news that EMEA has accepted the registration application of Xyotax (paclitaxel poliglumex), a drug for the treatment of lung cancer. Final approval will take 15 to 18 months.<\/p>\n

<\/span><\/font><\/p>\n

","protected":false},"excerpt":{"rendered":"

Schering: tagli per 1,5 mld di dollari entro il 2012 (The Wall Street Journal online – 3 aprile 2008) Schering-Plough taglierà i costi aziendali per un valore di 1,5 mld di dollari entro il 2012 a seguito delle indicazioni di un panel di cardiologi che suggerisce ai medici di limitare la prescrizione dei farmaci anticolesterolo …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12164","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12164"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12164\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}